AMERICAN COLLEGE OF SURGEONS ONCOLOGY TRIALS GROUP

美国外科医生学会(ACS)成立了美国 外科医学院肿瘤学小组(ACSOG)将进行多中心 旨在评估外科手术的作用的合作小组试验 恶性实体瘤患者的治疗程序。 外科临床试验小组的存在对 由于外科手术在肿瘤治疗中的主要作用 癌症患者的治疗。这些试验还将评估 选定的新操作、技术和仪器的效用，如 它们被引入到临床实践中。此外，ACSOG将 根据基础科学的新发现进行试验； 具体地说，(A)新的分子标记在 癌症患者的诊断和治疗；及(B) 介入治疗的患者被证明具有遗传性 有患癌症的倾向。通过其实质性的教育和 通信计划美国计算机协会将把重点放在 对外科医生进行临床试验方法学和 他们参与ACSOG临床试验计划的重要性。 美国医学会是世界上最大的外科医生组织，拥有广泛的 地域成员分布，包括普通外科医生和 学术医疗中心和私立医院的专科外科医生 实践社区。此外，癌症委员会(COC)， 美国癌症协会通过批准、教育、癌症联络和国家癌症 数据库程序拥有一大批活跃的专业人员和 服务于癌症项目并与之互动的志愿者 全美1500家经批准的医院的执业外科医生 美利坚合众国和加拿大。 ACSOG致力于对患有癌症的患者进行临床试验 最常见的恶性实体瘤。这是有目共睹的 初试集中在乳房患者身上 癌症、肺癌和结直肠癌。这些产品的性能 试验将需要在北美拥有广泛的执业外科医生基础 这一组参与者在成员中得到了很好的代表 美国国家航空航天局。

The American College of Surgeons (ACS) has established the American College of Surgeons Oncology Group (ACSOG) to conduct multicenter cooperative group trials designed to evaluate the role of surgical procedures in the treatment of patients with malignant solid tumors. The existence of a surgical clinical trial group is important to the oncological community because of the primary role of surgery in the treatment of the cancer patient. The trials will also evaluate the utility of selected new operations, technology, and instrumentation as they are introduced into clinical practice. Furthermore, the ACSOG will perform trials that are based on new basic science discoveries; specifically (a) the evaluation of new molecular markers in the diagnosis and treatment of the cancer patient and (b) the place of interventional therapy in patients demonstrated to have a genetic predisposition for cancer. Through its substantial education and communication programs the ACS will place great emphasis on the education of surgeons in clinical trial methodology and in the importance of their participation in the ACSOG clinical trials programs. The ACS is the largest organization of surgeons in the world with broad geographic membership distribution, including general surgeons and speciality surgeons in both academic medical centers and the private practice community. Furthermore, the Commission on Cancer (COC), of the ACS through the Approvals, Education, Cancer Liaison and National Cancer Database Programs has a large number of active professional staff and volunteers that serve and interact with the Cancer Programs and the practicing surgeons in the 1500 approved hospitals throughout the United States of America and Canada. The ACSOG is committed to performing clinical trials of patients with the most commonly occurring malignant solid tumors. This is evidenced b the concentration of the initial trials on patients with breast cancer, lung cancer and colorectal cancer. The performance of these trials will require a broad base of practicing surgeons in North America and this group of participants is well represented within the membership of the ACS.